Significant increase in the prevalence of Panton-Valentine leukocidin-positive methicillin-resistant

Panton–Valentine leukocidin USA300 methicillin-resistant Staphylococcus aureus ΨUSA300

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
06 Nov 2023
Historique:
medline: 6 11 2023
pubmed: 6 11 2023
entrez: 6 11 2023
Statut: aheadofprint

Résumé

USA300, a major Panton-Valentine leukocidin (PVL)-producing methicillin-resistant

Identifiants

pubmed: 37929951
doi: 10.1128/spectrum.01248-23
pmc: PMC10715091
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0124823

Références

Clin Infect Dis. 1999 Nov;29(5):1128-32
pubmed: 10524952
Proc Natl Acad Sci U S A. 2017 Dec 5;114(49):E10596-E10604
pubmed: 29158405
Clin Microbiol Infect. 2018 Nov;24(11):1211.e1-1211.e7
pubmed: 29454850
Lancet. 2002 Mar 2;359(9308):753-9
pubmed: 11888586
Pediatr Infect Dis J. 2022 Jan 1;41(1):12-19
pubmed: 34889869
J Infect Chemother. 2008 Dec;14(6):439-41
pubmed: 19089559
J Eur Acad Dermatol Venereol. 2012 Aug;26(8):931-41
pubmed: 22214317
J Infect Chemother. 2017 Aug;23(8):503-511
pubmed: 28645883
J Clin Microbiol. 2003 Sep;41(9):4089-94
pubmed: 12958230
Microb Drug Resist. 2015 Aug;21(4):441-7
pubmed: 25789579
Sci Rep. 2021 Mar 8;11(1):5447
pubmed: 33686133
S Afr Med J. 2015 Apr 06;105(5):325
pubmed: 26242647
J Antimicrob Chemother. 2023 Apr 3;78(4):1023-1027
pubmed: 36814074
J Antimicrob Chemother. 2020 Nov 1;75(11):3131-3134
pubmed: 32712671
Microb Drug Resist. 2022 Mar;28(3):330-337
pubmed: 35021886
PLoS One. 2011;6(7):e22407
pubmed: 21818321
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
J Dermatol. 2020 Nov;47(11):1280-1286
pubmed: 32696497
J Clin Microbiol. 2008 Feb;46(2):574-81
pubmed: 18032612
Microorganisms. 2020 Nov 05;8(11):
pubmed: 33167581
J Clin Microbiol. 2005 Jul;43(7):3356-63
pubmed: 16000460
Biol Pharm Bull. 2011;34(9):1469-73
pubmed: 21881235
Emerg Infect Dis. 2007 Apr;13(4):594-600
pubmed: 17553275
Clin Microbiol Infect. 2012 Aug;18(8):725-34
pubmed: 22448902
Eur J Med Res. 2010 Nov 30;15(12):544-53
pubmed: 21163729
Lancet. 2001 Apr 21;357(9264):1225-40
pubmed: 11418146
Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1323-9
pubmed: 27209287
Int J Antimicrob Agents. 2022 Mar;59(3):106534
pubmed: 35091056
Diagn Microbiol Infect Dis. 2019 May;94(1):86-87
pubmed: 30579658
J Infect Chemother. 2016 Jan;22(1):14-8
pubmed: 26617349
Science. 2007 Feb 23;315(5815):1130-3
pubmed: 17234914
J Antimicrob Chemother. 2022 Jul 28;77(8):2130-2141
pubmed: 35639590
Genome Res. 1998 Mar;8(3):186-94
pubmed: 9521922
Microbiol Spectr. 2022 Aug 31;10(4):e0227221
pubmed: 35758725
mBio. 2019 Nov 26;10(6):
pubmed: 31772058
J Glob Antimicrob Resist. 2021 Mar;24:207-214
pubmed: 33373735
J Infect Chemother. 2017 Nov;23(11):800-803
pubmed: 28552322
PLoS One. 2009 May 27;4(5):e5714
pubmed: 19492076
Lancet Infect Dis. 2013 Jan;13(1):43-54
pubmed: 23103172
Clin Infect Dis. 2014 Jul 15;59(2):147-59
pubmed: 24947530
Clin Microbiol Infect. 2020 Oct;26(10):1416.e1-1416.e4
pubmed: 32619735
J Clin Microbiol. 2011 Oct;49(10):3627-31
pubmed: 21832022
Antimicrob Agents Chemother. 2007 Jan;51(1):264-74
pubmed: 17043114
Sci Rep. 2023 May 23;13(1):8322
pubmed: 37221358
Clin Ther. 2021 Jun;43(6):986-1006
pubmed: 34053699
Front Microbiol. 2021 Feb 10;12:631845
pubmed: 33643261
Clin Microbiol Infect. 2007 Sep;13(9):843-5
pubmed: 17686137
J Med Microbiol. 2018 Mar;67(3):392-399
pubmed: 29458554
Microbiol Spectr. 2022 Feb 23;10(1):e0203721
pubmed: 35138159

Auteurs

Hiroshi Kaneko (H)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Miki Kanai (M)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Takumi Saito (T)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Yuka Yanagi (Y)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Hana Kobayashi (H)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Rikuto Kurihara (R)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Masami Ikeda (M)

Department of Dermatology, Takamatsu Red Cross Hospital, Kagawa, Japan.

Osamu Nemoto (O)

Sapporo Skin Clinic, Hokkaido, Japan.

Naoko Baba (N)

Department of Dermatology, Kanagawa Children's Medical Center, Kanagawa, Japan.

Yasushi Matsuzaki (Y)

Department of Dermatology, Hirosaki University Graduate School of Medicine, Aomori, Japan.

Daisuke Sawamura (D)

Department of Dermatology, Hirosaki University Graduate School of Medicine, Aomori, Japan.

Fumiko Shimoe (F)

Shimoe Dermatology Clinic, Osaka, Japan.

Yoichi Inaba (Y)

Atopia Clinic, Kumamoto, Japan.

Yoko Kobayashi (Y)

Kobayashi Dermatology Clinic, Tokyo, Japan.

Satoru Kawasaki (S)

Kawasaki Dermatology Clinic, Tokyo, Japan.

Toru Ueki (T)

Ueki Dermatology Plastic Surgery, Tokyo, Japan.

Sakae Funatsu (S)

Kawano Dermatology Clinic, Tokyo, Japan.

Shigeho Shirahama (S)

Department of Dermatology, Seirei Mikatahara General Hospital, Shizuoka, Japan.

Misao Oba (M)

Department of Dermatology, Seirei Mikatahara General Hospital, Shizuoka, Japan.

Takaya Hasegawa (T)

Hasegawa Dermatology Clinic, Fukushima, Japan.

Hirotoshi Furukawa (H)

Furukawa Dermatology Clinic, Fukushima, Japan.

Toshiko Miyata (T)

Division of Dermatology, Saitama Citizens Medical Center, Saitama, Japan.

Masaaki Isonokami (M)

Isonokami Dermatological Clinic, Osaka, Japan.

Shigeru Fujita (S)

Fujita Dermatological Clinic, Niigata, Japan.

Hidemasa Nakaminami (H)

Department of Clinical Microbiology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Classifications MeSH